+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infusions And Injectables Market Research Reports

From
Microneedle Market - Product Thumbnail Image

Microneedle Market

  • Report
  • December 2023
  • 123 Pages
  • Global
From
Solid Microneedles: Global Market Outlook - Product Thumbnail Image

Solid Microneedles: Global Market Outlook

  • Report
  • November 2022
  • 41 Pages
  • Global
From
Autoinjectors: Global Markets 2021-2026 - Product Thumbnail Image

Autoinjectors: Global Markets 2021-2026

  • Report
  • November 2021
  • 123 Pages
  • Global
From
Needle-Free Devices: Technologies and Global Markets - Product Thumbnail Image

Needle-Free Devices: Technologies and Global Markets

  • Report
  • March 2019
  • 170 Pages
  • Global
From
Intravenous (IV) Therapy and Vein Access: Global Markets - Product Thumbnail Image

Intravenous (IV) Therapy and Vein Access: Global Markets

  • Report
  • December 2018
  • 259 Pages
  • Global
From
Self-administered Injectable Drug Therapies and Markets - Product Thumbnail Image

Self-administered Injectable Drug Therapies and Markets

  • Report
  • September 2023
  • 234 Pages
  • Global
From
Injectable Hematology Growth Factors Report - Product Thumbnail Image

Injectable Hematology Growth Factors Report

  • Report
  • January 2024
  • Global
From
Chronic Disease Markets for Sustained Released Injectables - Product Thumbnail Image

Chronic Disease Markets for Sustained Released Injectables

  • Report
  • December 2023
  • 217 Pages
  • Global
From
Therapeutic Injectable Drugs - Devices, Products and Markets - Product Thumbnail Image

Therapeutic Injectable Drugs - Devices, Products and Markets

  • Report
  • June 2023
  • 235 Pages
  • Global
From
Extended Release Injectable Drugs - Product Thumbnail Image

Extended Release Injectable Drugs

  • Report
  • June 2023
  • 200 Pages
  • Global
From
Microneedle Measurable Chronic Disease Biomarkers - Product Thumbnail Image

Microneedle Measurable Chronic Disease Biomarkers

  • Report
  • June 2022
  • 138 Pages
  • Global
From
Drug Injection Devices to 2028 - Product Thumbnail Image

Drug Injection Devices to 2028

  • Report
  • April 2022
  • 230 Pages
  • Global
From
Digital Management of Chronic Injectable Drug Patients - Product Thumbnail Image

Digital Management of Chronic Injectable Drug Patients

  • Report
  • April 2022
  • 120 Pages
  • Global
From
From
Medical Microneedle Diagnostics - Product Thumbnail Image

Medical Microneedle Diagnostics

  • Report
  • January 2022
  • 125 Pages
  • Global
Reconstituting Injectables at the Point-of-Care - Product Thumbnail Image

Reconstituting Injectables at the Point-of-Care

  • Report
  • January 2022
  • 100 Pages
  • Global
Long-Acting Injectable Drugs - Product Thumbnail Image

Long-Acting Injectable Drugs

  • Report
  • December 2021
  • 170 Pages
  • Global
Loading Indicator

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share. The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects. Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more